Denver, CO · Founded 2019 · Privately Held (backing)
Developer of a remote patient monitoring device designed to enhance healthcare delivery. BioIntelliSense is based in Denver, CO and was founded in 2019. Its last reported valuation was $1.2 billion in Dec 2022. It has raised $319 million across 4 recorded rounds; the latest was a $58.3 million later-stage round in Dec 2025.
Last reported valuation
$1.2B
Oct 2026
Priced at
—
Total raised
$318.6M
Last round
Later Stage VC
Dec 2025
Cap table — not yet on record
BioIntelliSense's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of BioIntelliSense with a free account
·The complete investor list: 18 names
·Watch BioIntelliSense: the Monday email on marks, rounds and moves
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across BioIntelliSense's 4 recorded funding rounds.
